Literature DB >> 6141395

Scintigraphic imaging of neuroblastoma with [131-I]iodobenzylguanidine.

J Treuner, U Feine, D Niethammer, W Müller-Schaumburg, J Meinke, E Eibach, R Dopfer, T Klingebiel, S Grumbach.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6141395     DOI： 10.1016/s0140-6736(84)90375-1

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  32 in total

1.  Semi-quantitative scoring of skeletal metastases by 123I-mIBG scintigraphy in high-risk neuroblastoma.

Authors:  Mark N Gaze
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-03-03       Impact factor: 9.236

2.  Tumor dosimetry using [124I]m-iodobenzylguanidine microPET/CT for [131I]m-iodobenzylguanidine treatment of neuroblastoma in a murine xenograft model.

Authors:  Youngho Seo; W Clay Gustafson; Shorouk F Dannoon; Erin A Nekritz; Chang-Lae Lee; Stephanie T Murphy; Henry F VanBrocklin; Miguel Hernandez-Pampaloni; Daphne A Haas-Kogan; William A Weiss; Katherine K Matthay
Journal:  Mol Imaging Biol       Date:  2012-12       Impact factor: 3.488

3.  Patient-specific dosimetry using pretherapy [¹²⁴I]m-iodobenzylguanidine ([¹²⁴I]mIBG) dynamic PET/CT imaging before [¹³¹I]mIBG targeted radionuclide therapy for neuroblastoma.

Authors:  Shih-ying Huang; Wesley E Bolch; Choonsik Lee; Henry F Van Brocklin; Miguel H Pampaloni; Randall A Hawkins; Aimee Sznewajs; Steven G DuBois; Katherine K Matthay; Youngho Seo
Journal:  Mol Imaging Biol       Date:  2015-04       Impact factor: 3.488

Review 4.  Imaging of neuroblastoma: an overview.

Authors:  A Bousvaros; D R Kirks; H Grossman
Journal:  Pediatr Radiol       Date:  1986

5.  Coincidence of infectious osteomyelitis and disseminated neuroblastoma: a diagnostic dilemma solved by scintigraphic imaging.

Authors:  W Kiess; B Leisner; R Haas
Journal:  J Cancer Res Clin Oncol       Date:  1985       Impact factor: 4.553

6.  131I-meta-iodobenzylguanidine scintigraphy in patients with neuroblastoma.

Authors:  S Hibi; S Todo; S Imashuku; T Miyazaki
Journal:  Pediatr Radiol       Date:  1987

7.  Semiquantitative mIBG scoring as a prognostic indicator in patients with stage 4 neuroblastoma: a report from the Children's oncology group.

Authors:  Gregory A Yanik; Marguerite T Parisi; Barry L Shulkin; Arlene Naranjo; Susan G Kreissman; Wendy B London; Judith G Villablanca; John M Maris; Julie R Park; Susan L Cohn; Patrick McGrady; Katherine K Matthay
Journal:  J Nucl Med       Date:  2013-02-25       Impact factor: 10.057

8.  Different outcomes for relapsed versus refractory neuroblastoma after therapy with (131)I-metaiodobenzylguanidine ((131)I-MIBG).

Authors:  Margaret J Zhou; Michelle Y Doral; Steven G DuBois; Judith G Villablanca; Gregory A Yanik; Katherine K Matthay
Journal:  Eur J Cancer       Date:  2015-08-05       Impact factor: 9.162

9.  Uptake of 131I-MIBG by medullary carcinoma of thyroid in familial cases.

Authors:  G Coutris; J N Talbot; G Kabla; C Calmettes; G Milhaud
Journal:  Eur J Nucl Med       Date:  1986

Review 10.  Radiolabeled metaiodobenzylguanidine for the treatment of neuroblastoma.

Authors:  Steven G DuBois; Katherine K Matthay
Journal:  Nucl Med Biol       Date:  2008-08       Impact factor: 2.408
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.